Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Tyndall

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Hematology. American Society of Hematology. Education Program|December 14, 2011
Successes and failures of stem cell transplantation in autoimmune diseasesAlan Tyndall
Nature Clinical Practice. Rheumatology|May 15, 2008
Why do we need noncommercial, investigator-initiated clinical trials?Alan Tyndall
Current Pharmaceutical Design|May 23, 2012
Modern therapeutic strategies for autoimmune diseasesAlan Tyndall
Rheumatology (Oxford, England)|October 18, 2017
Primary angiitis of the central nervous system-a territory about to be discoveredThomas Daikeler, Alan Tyndall
Expert Review of Clinical Immunology|May 19, 2010
Progress in hematopoietic stem cell transplantation for autoimmune diseasesAlan Tyndall, Dominique Farge
Nature Medicine|January 9, 2009
Mesenchymal stem cells combat sepsisAlan Tyndall, Vito Pistoia
Acta Haematologica|November 5, 2005
Autologous hematopoietic stem cell transplantation for autoimmune diseasesAlan Tyndall, Thomas Daikeler
International Journal of Hematology|November 15, 2002
The use of high dose immunoablative therapy with hematopoietic stem cell support therapy in the treatment of severe autoimmune diseasesAlan Tyndall, Alois Gratwohl
Current Opinion in Hematology|May 26, 2009
Adult stem cell transplantation in autoimmune diseaseAlan Tyndall, Alois Gratwohl
Internal Medicine (Tokyo, Japan)|September 5, 2002
High-dose immunoablative therapy with hematopoietic stem cell support in the treatment of severe autoimmune disease: current status and future directionAlan Tyndall, Takao Koike
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Hematology. American Society of Hematology. Education Program|December 14, 2011
Successes and failures of stem cell transplantation in autoimmune diseasesAlan Tyndall
Nature Clinical Practice. Rheumatology|May 15, 2008
Why do we need noncommercial, investigator-initiated clinical trials?Alan Tyndall
Current Pharmaceutical Design|May 23, 2012
Modern therapeutic strategies for autoimmune diseasesAlan Tyndall
Rheumatology (Oxford, England)|October 18, 2017
Primary angiitis of the central nervous system-a territory about to be discoveredThomas Daikeler, Alan Tyndall
Expert Review of Clinical Immunology|May 19, 2010
Progress in hematopoietic stem cell transplantation for autoimmune diseasesAlan Tyndall, Dominique Farge
Nature Medicine|January 9, 2009
Mesenchymal stem cells combat sepsisAlan Tyndall, Vito Pistoia
Acta Haematologica|November 5, 2005
Autologous hematopoietic stem cell transplantation for autoimmune diseasesAlan Tyndall, Thomas Daikeler
International Journal of Hematology|November 15, 2002
The use of high dose immunoablative therapy with hematopoietic stem cell support therapy in the treatment of severe autoimmune diseasesAlan Tyndall, Alois Gratwohl
Current Opinion in Hematology|May 26, 2009
Adult stem cell transplantation in autoimmune diseaseAlan Tyndall, Alois Gratwohl
Internal Medicine (Tokyo, Japan)|September 5, 2002
High-dose immunoablative therapy with hematopoietic stem cell support in the treatment of severe autoimmune disease: current status and future directionAlan Tyndall, Takao Koike
Pageof 11